Advertisement
Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 3.8400 |
| Open | 3.8400 |
| Bid | 3.7000 x 100 |
| Ask | 3.7600 x 100 |
| Day's Range | 3.6900 - 3.8925 |
| 52 Week Range | 2.3000 - 9.7450 |
| Volume | |
| Avg. Volume | 3,083,564 |
| Market Cap | 391.284M |
| Beta (5Y Monthly) | 0.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.3400 |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.23 |
ZacksRevance Therapeutics, Inc. (RVNC) Reports Q3 Loss, Lags Revenue Estimates
Revance Therapeutics (RVNC) delivered earnings and revenue surprises of -5.71% and 11.60%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update
NASHVILLE, Tenn., November 07, 2024--Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.